Document Type
Article
Date
2016
Date of Submission
November 2016
Abstract
VCU researchers are experimenting with a new drug that targets the chaperone proteins that protect cancer cells. The drug AR-12 has the potential to fight off not only cancer but also Ebola, Zika and the human immunodeficiency virus, as well as bacterial infections.
Rights
© The Author(s)
Is Part Of
The Scope
Comments
The Scope showcases student-produced news articles about research and researchers at VCU.